Vistagen Therapeutics Inc
For the period ended Mar 31, 2024. Filed Jun 11, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Jun 11, 2024
VTGN$0.18-0.7%Stored close · as of Nov 10, 2026
Opening this filing…